Imagion Biosystems announces on ASX that it has received a total of $3500 for the exercise of 70,000 Listed Options exercisable at 5 cents, expiring on 26 November 2021.
Please click to review the full announcement at ASX.
Quarterly Activity Report – Quarter ending 31 December 2023
January 31, 2024
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal